Đang chuẩn bị liên kết để tải về tài liệu:
Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Microvascular invasion (MVI) is recognized as a prognostic factor associated with poor outcome in hepatocellular carcinoma (HCC) patients after curative resection. It remains unclear, however, whether MVI can provide prognostic information for patients at a specific tumor stage. |

TÀI LIỆU LIÊN QUAN

Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: A non-randomized interventional clinical study

The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: A propensity score matching analysis

Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion

Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: A multicenter study from China

A predictive and prognostic model for hepatocellular carcinoma with microvascular invasion based TCGA database genomics

Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B

Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma

When to call it off: Defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma